Long-term outcomes of intravitreal activated protein C injection for ischemic central retinal vein occlusion: an extension trial

PURPOSE: Our previous 1-year pilot study evaluated the efficacy of intravitreally injected activated protein C (APC) in 10 eyes with ischemic central retinal vein occlusion (CRVO). The reperfusion of the areas of retinal nonperfusion (RNP) exceeded 50% of the baseline in five (50%) eyes 1 year after...

Descripción completa

Detalles Bibliográficos
Autores principales: Hara, Chikako, Kamei, Motohiro, Sakaguchi, Hirokazu, Matsumura, Nagakazu, Sakimoto, Susumu, Suzuki, Mihoko, Nishida, Kentaro, Fukushima, Yoko, Nishida, Kohji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478745/
https://www.ncbi.nlm.nih.gov/pubmed/33893866
http://dx.doi.org/10.1007/s00417-021-05072-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478745/
https://www.ncbi.nlm.nih.gov/pubmed/33893866
http://dx.doi.org/10.1007/s00417-021-05072-9

Ejemplares similares